Lupisolone 4mg Tablet contains Methylprednisolone, a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties. It is primarily indicated for the management of various inflammatory and autoimmune conditions, including allergic reactions, asthma, rheumatoid arthritis, lupus erythematosus, and certain dermatological disorders. Methylprednisolone acts by inhibiting the release of inflammatory mediators and suppressing the immune response, thereby reducing inflammation, swelling, and associated symptoms. The 4mg dosage allows for flexible titration according to the severity of the condition and patient response. Lupisolone should be administered under medical supervision, with dosage and duration tailored to individual clinical needs to minimize potential adverse effects such as immunosuppression, hyperglycemia, osteoporosis, and adrenal suppression. It is contraindicated in patients with systemic fungal infections and should be used cautiously in those with hypertension, diabetes, or peptic ulcer disease. Abrupt discontinuation after prolonged therapy is not recommended due to the risk of adrenal insufficiency; gradual tapering is advised. Patients should be monitored regularly for therapeutic efficacy and side effects. Lupisolone 4mg Tablet is a valuable therapeutic agent in the management of diverse inflammatory and autoimmune disorders, providing effective symptom control when used appropriately.